Featured Research

from universities, journals, and other organizations

Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer

Date:
February 3, 2009
Source:
Cell Press
Summary:
New research reveals how a cancer-associated protein enables tumor cells to evade the immune system by both suppressing anti-tumor influences and promoting tumor-enhancing conditions, in essence turning the immune system to the dark side of the force. The study is published by Cell Press in the Feb. 3 issue of the journal Cancer Cell.

New research reveals how a cancer-associated protein enables tumor cells to evade the immune system by both suppressing antitumor influences and promoting tumor-enhancing conditions, in essence turning the immune system to the dark side of the force. The study is published by Cell Press in the February 3rd issue of the journal Cancer Cell.

Related Articles


Continuous activation of the transcription factor Stat3 contributes to the survival and proliferation of cancer cells. Activated Stat3 suppresses antitumor activity by stimulating immunosuppressive factors and by inhibiting expression of chemicals that are critical for antitumor immunity. In addition to tumor cells themselves, Stat3 is activated in many different types of immune cells present in the tumor microenvironment, such as macrophages and dendritic cells, facilitating the crosstalk between tumor cells and tumor-associated immune cells.

Recent research has suggested that the cytokine IL-23 has tumor-promoting effects while the closely related cytokine IL-12 has anti-tumor characteristics. "Although results from previous studies have suggested that IL-23 and IL-12 may play opposite roles in cancer progression, the specific mechanisms of action in tumor regulation have not been elucidated," explains study author Dr. Drew Pardoll from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine.

Drs. Hua Yu, Marcin Kortylewski and Hong Xin from the Beckman Research Institute at City of Hope in Duarte, California and Dr. Pardoll, investigated how IL-23 and IL-12 are differentially regulated in the tumor microenvironment. The researchers found that Stat3 induced expression of IL-23 in tumor-associated macrophages and inhibited expression of IL-12 in tumor-associated dendritic cells.

Unexpectedly, IL-23 receptor was upregulated in regulatory T cells within the tumor microenvironment and enhanced their immunosuppressive activity. In these cells, the IL-23 receptor activates Stat3 and leads to production of the immunosuppressive cytokine IL-10.

Taken together, these findings demonstrate that Stat3 promotes IL-23-related pro-cancer immune responses and concurrently inhibits IL-12-dependent antitumor immunity. "Because Stat3 is a point of convergence for signaling pathways commonly activated in cancer, our data reveal a mechanism by which oncogenic pathways regulate the immune microenvironment to promote tumor development," concludes Dr. Yu.

The researchers include Marcin Kortylewski, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Hong Xin, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Maciej Kujawski, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Heehyoung Lee, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Yong Liu, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA; Timothy Harris, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; Charles Drake, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; Drew Pardoll, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD; and Hua Yu, Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, CA.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer." ScienceDaily. ScienceDaily, 3 February 2009. <www.sciencedaily.com/releases/2009/02/090202174457.htm>.
Cell Press. (2009, February 3). Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2009/02/090202174457.htm
Cell Press. "Stat3 Signaling Tips The Balance Of Immunity In Favor Of Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/02/090202174457.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins